Who Paid My Doc
Marc Gannon
Optometrist, Low Vision Rehabilitation Ft Lauderdale, FL Doctor of Optometry
NPI 1841286424 CMS profile 415493
2021 E Commercial Blvd, Suite #301, Ft Lauderdale, FL 33308
General payments
$141
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Marc Gannon of Ft Lauderdale, FL is reported in the CMS Open Payments database as having received $141 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 38th percentile of Optometrist, Low Vision Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $141 | 1 |
Beside peers
- Marc Gannon
- Optometrist, Low Vision Rehabilitation median
- Middle half of Optometrist, Low Vision Rehabilitation
- National median
In program year 2025, general payments to Marc Gannon were reported at $0. Among 89 Optometrist, Low Vision Rehabilitation profiles paid that year, the median was $150 and the middle half received between $50 and $382.
Show as a table
| Year | Marc Gannon | Optometrist, Low Vision Rehabilitation median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $126 | $62–$303 | $163 |
| 2020 | $0 | $57 | $19–$124 | $114 |
| 2021 | $0 | $137 | $48–$277 | $132 |
| 2022 | $141 | $135 | $53–$282 | $149 |
| 2023 | $0 | $141 | $52–$361 | $160 |
| 2024 | $0 | $146 | $75–$336 | $164 |
| 2025 | $0 | $150 | $50–$382 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$43,241
Medicare patients
215
Services billed
796
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 51% | |
| Ischemic heart disease | 47% | |
| Diabetes | 38% | |
| Chronic kidney disease | 36% | |
| Atrial fibrillation | 31% | |
| Depression | 28% | |
| Heart failure | 27% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Low Vision Rehabilitation in Florida
Anne Menjivar
Optometrist, Low Vision Rehabilitation · Ocala, FL
Rosemary Carrera
Optometrist, Low Vision Rehabilitation · Miami, FL
Jenny Lee
Optometrist, Low Vision Rehabilitation · Riviera Beach, FL
Edward Huggett
Optometrist, Low Vision Rehabilitation · Dunedin, FL
Xiao Yu
Optometrist, Low Vision Rehabilitation · Davie, FL
Luc Kanicky
Optometrist, Low Vision Rehabilitation · Tampa, FL
Related records
Optometrist, Low Vision Rehabilitation in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Low Vision Rehabilitation
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.